The STARS project (2017-2022) focused on eHealth/mHealth self-management tools for hospitalised and outpatient care continuity.
FUNDACIO INSTITUT D'INVESTIGACIÓ I INNOVACIÓ PARC TAULI
Spanish hospital-linked research foundation specializing in digital patient empowerment, innovative health procurement, and clinical validation of care innovations.
Their core work
I3PT is the research and innovation foundation linked to Parc Taulí University Hospital in Sabadell, Spain. They focus on translating clinical research into improved patient care, with particular expertise in digital health tools, patient empowerment strategies, and innovative healthcare procurement. Their work bridges the gap between hospital-based clinical practice and EU-funded health innovation, contributing real-world clinical settings and patient populations to research consortia.
What they specialise in
EURIPHI (2019-2020) specifically addressed pre-commercial procurement of health innovations including rapid diagnostics and integrated care.
Contributed as third party to 2-NanoSi (2015-2016), developing nanosensors for trypsin-related diseases including cystic fibrosis.
Both STARS and EURIPHI addressed cost-effectiveness and value-based approaches to healthcare delivery and service transition.
How they've shifted over time
I3PT's H2020 trajectory shows a clear shift from laboratory-oriented nanomedicine (2015-2016, via 2-NanoSi and cystic fibrosis nanosensors) toward health system innovation and digital patient services (2017-2022). Their later projects focus heavily on eHealth, mHealth, patient empowerment, and innovative procurement — all pointing toward healthcare delivery transformation rather than bench science. This evolution suggests the foundation moved from supporting basic research to actively shaping how hospitals adopt and procure new health technologies.
I3PT is moving toward health system transformation — digital tools, procurement innovation, and value-based care — making them a strong fit for future projects on hospital digitalization and patient-centered service design.
How they like to work
I3PT operates exclusively as a participant or third party — they have never coordinated an H2020 project. With 38 unique partners across 12 countries from just 3 projects, they join large, broadly distributed consortia rather than leading small focused teams. This profile suggests a clinical end-user partner that contributes hospital infrastructure, patient access, and real-world validation rather than driving project management.
Despite only 3 projects, I3PT has built connections with 38 partners across 12 countries, reflecting participation in large pan-European health consortia. Their network is geographically broad with no obvious concentration beyond Spain.
What sets them apart
I3PT brings something many research foundations cannot: direct access to a working university hospital environment (Parc Taulí) for piloting and validating health innovations with real patients. Their combination of clinical infrastructure and experience with innovative procurement (PCP/PPI) makes them valuable for projects that need to demonstrate real-world impact in a hospital setting. For consortium builders, they offer a Spanish clinical validation site with established experience in digital health deployment.
Highlights from their portfolio
- STARSLargest project by funding (EUR 125,550) and duration (5 years), focused on the full patient journey from hospital to home using eHealth/mHealth tools.
- EURIPHIAddressed the rarely-covered topic of innovative health procurement (PCP), positioning I3PT at the intersection of healthcare purchasing and technology adoption.